Preferred Name |
4-demethoxydaunorubicin bis(hydrazone) |
|
Synonyms |
SC 33428 SC-33428 SC33428 Pentanedioic acid, 3-amino-, bis((1-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-6,11-dioxo-2-naphthacenyl)ethylidene)hydrazide), trihydrochloride, (2S-(2alpha,2(2R*,4R*),4alpha))- |
|
ID |
http://purl.bioontology.org/ontology/MESH/C037799 |
|
altLabel |
SC 33428 SC-33428 SC33428 Pentanedioic acid, 3-amino-, bis((1-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-6,11-dioxo-2-naphthacenyl)ethylidene)hydrazide), trihydrochloride, (2S-(2alpha,2(2R*,4R*),4alpha))- |
|
cui |
C0284597 C0096907 |
|
Has mapping qualifier | ||
HM |
D015255/Q000031 |
|
Inverse of RB |
77313-12-3 |
|
Mapped to | ||
MDA |
19830609 |
|
MeSH Frequency |
2 |
|
MMR |
20011211 |
|
notation |
C037799 |
|
PI |
DAUNORUBICIN/*analogs (83-88) |
|
prefLabel |
4-demethoxydaunorubicin bis(hydrazone) |
|
SC |
1 |
|
Scope Statement |
structure given in first source |
|
SRC |
Cancer Res 1983;43(6):2880 |
|
TERMUI |
T144147 T144146 T144145 T144144 |
|
TH |
NLM (1983) |
|
tui |
T109 T121 |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://purl.bioontology.org/ontology/PDQ/CDR0000039753 | PDQ | CUI | |
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C037799 | RH-MESH | LOOM |